A patient can be ready to leave the hospital and still have no safe way to get home. In my experience, the missing piece is, not uncommonly, the oxygen equipment they need.
While we can prescribe oxygen, document the flow rate, and arrange follow-up, if the right equipment isn’t available, the discharge plan stops there. Can’t move forward. For patients who need substantial oxygen while moving around, the problem can follow them home, limiting their ability to leave the house, attend appointments, or participate in pulmonary rehab.
Congress has been considering a bill that takes on some of the payment and paperwork behind these gaps. The Supplemental Oxygen Access Reform Act of 2025, or SOAR Act, would change how Medicare pays for oxygen equipment and services, including liquid oxygen and respiratory therapist support.
In this article, I’ll break down the proposal, the reimbursement system it aims to change, and what it could mean for pulmonary practice.
The News: A Push to Reform Home Oxygen
The SOAR Act was introduced in both the House and the Senate in April 2025. It has bipartisan support, but it has not become law. As of this writing, Congress.gov lists both bills as introduced and referred to committee.
In a September 2026 update, HME News reported that more than 300 people who use supplemental oxygen had met with lawmakers and staff to push for the bill. Advocates called for Congress to act before the end of the 119th Congress.
The Deets: How Medicare Pays for Oxygen and What SOAR Would Change
Medicare treats home oxygen as durable medical equipment. Under the current payment policy, oxygen equipment is generally paid for through monthly rental payments, capped at 36 months. The rental allowance includes items and services such as tubing, delivery, maintenance, and repairs.
After the rental cap, the supplier generally must continue furnishing the equipment and required services through the equipment’s five-year reasonable useful lifetime. Some payments for oxygen contents or maintenance may still apply, so it would be misleading to say every oxygen-related payment stops after month 36.
That payment structure is important because oxygen delivery is an ongoing service. Suppliers need equipment, staff, storage, transportation, and a way to respond when something breaks. Liquid oxygen has additional logistical demands, including storage and refills. If payment doesn’t adequately reflect those costs, suppliers may be less willing or able to offer it. The resulting shortage can leave patients and clinicians with fewer options.
There’s an important nuance about competitive bidding. Oxygen was included in earlier rounds, but Medicare’s competitive bidding program is currently in a gap period, and oxygen is not among the products CMS has announced for its next round. Existing fee schedules can still reflect earlier bidding information. SOAR would formally exclude oxygen from the program and establish new payment formulas. It wouldn’t end an active oxygen bidding round today. More on Medicare’s payment structure.
Here’s what the introduced House bill would do:
Change oxygen payment. The bill proposes geography-specific payment formulas and inflation updates. It also directs CMS to create a separate liquid oxygen payment, with a floor based on twice the 2015 fee schedule adjusted for inflation through 2025.
Recognize higher liquid oxygen needs. The bill calls for an additional monthly payment for liquid oxygen when the prescribed flow is at least 6 liters per minute. CMS would also establish objective clinical coverage criteria and periodically review them. This is a proposed liquid oxygen payment provision, not a rule that every patient at that flow rate automatically qualifies for liquid oxygen.
Pay for respiratory therapist services. The bill would cover respiratory therapist assessment, treatment, and monitoring related to oxygen within the applicable state scope of practice, with a monthly payment add-on reflecting the cost of clinically appropriate services. CMS would work out the details through rulemaking.
Standardize documentation. A prescribing practitioner would complete an electronic template covering the required visit, qualifying blood gas or saturation results, and equipment need. The bill allows CMS to request other appropriate documentation on the template, but says it cannot require the practitioner’s medical record notes as part of that request. It would also direct Medicare to use clinical judgment when auditing supplier claims.
Define supplier responsibilities and patient protections. These include education, safety assessment, timely delivery and setup, equipment support, 24-hour on-call coverage, and help coordinating oxygen during travel. The bill also calls for protections around supplier choice, communication, grievances, and information about cost-sharing.
Dashevsky’s Dissection
As pulmonologists, we know that prescribing oxygen is only one part of the work. The patient needs a system that delivers the prescribed flow in the settings where they actually need it—and equipment they can manage safely outside the hospital.
This becomes especially important during exertion. A patient with interstitial lung disease or pulmonary hypertension may have different oxygen needs sitting in clinic than walking to the bathroom or leaving home. A portable concentrator, compressed-gas cylinder, and liquid oxygen system are not interchangeable for every patient: flow delivery, duration, weight, and refill availability all matter.
The American Thoracic Society guideline conditionally suggests portable liquid oxygen for patients who are mobile outside the home and require more than 3 liters per minute of continuous-flow oxygen during exertion. The evidence was rated very low quality, though. That clinical recommendation also uses a different threshold from the bill’s proposed liquid oxygen payment add-on at 6 liters per minute.
I think the bill’s strongest feature is that it treats oxygen as a service that has to work in a patient’s life. Paying attention to mobility, education, backup equipment, and respiratory therapist support gets closer to what patients need after the prescription is written.
I’ve previously covered a respiratory therapist–led home-visit program for patients with COPD. That was a different intervention from SOAR’s proposed oxygen benefit, but it highlighted how much respiratory care happens after discharge, and how important support at home can be.
For our practices, a standardized template could reduce the back-and-forth over documentation. But the result will depend on how CMS builds it, how it fits into our electronic records, and whether suppliers and contractors use it consistently. An electronic form alone won’t solve a local shortage of equipment or delivery capacity.
Higher payment also has tradeoffs. It could make liquid oxygen more sustainable for suppliers, but it may increase Medicare spending and, depending on coverage and supplemental insurance, patients’ out-of-pocket costs. The bill doesn’t establish that those costs will be offset by shorter stays or fewer readmissions. We’d need to measure those outcomes rather than assume them.
Until the rules change, I’d keep a few practical steps in mind:
Start the oxygen plan early. Ask case management and local suppliers what equipment can actually meet the patient’s prescribed needs, especially if those needs are high or increase with activity.
Document the clinical picture and qualifying testing. For oxygen first prescribed at hospital discharge, Medicare contractors state that qualifying testing must be performed within two days before discharge. Confirm the applicable criteria and required documentation for the patient’s situation. See the DME Medicare contractors’ guidance.
Plan beyond the bedside. Confirm the patient and caregiver understand the equipment, safety precautions, backup plan, and how to reach the supplier. Arrange reassessment when oxygen was started during an acute illness, since needs can change after recovery.
In summary, the SOAR Act proposes a meaningful redesign of how Medicare pays for and supports home oxygen. Whether it improves access will depend on the final legislation, CMS implementation, supplier participation, and whether patients can actually obtain equipment that meets their needs.



